- Home
- CERT
CERT
Certara Inc.
as 11-15-2024 2:33pm EST
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | RADNOR |
| Market Cap: | 1.6B | IPO Year: | 2020 |
| Target Price: | $15.92 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.88 - $19.87 | Next Earning Date: | 11-06-2024 |
| Revenue: | $372,797,000 | Revenue Growth: | 5.62% |
| Revenue Growth (this year): | 10.39% | Revenue Growth (next year): | 10.57% |
Stock Insider Trading Activity of Certara Inc. (CERT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SMITH PATRICK F | CERT | PRESIDENT, DRUG DEV SOLUTIONS | Oct 7 '24 | Sell | $11.03 | 5,409 | $59,661.27 | 50,091 | |
| Pedersen Leif E | CERT | PRESIDENT, CHIEF COMMERCAL OFF | Sep 9 '24 | Sell | $11.29 | 51,224 | $578,318.96 | 99,704 |
Latest Certara Inc. News
CERT Breaking Stock News: Dive into CERT Ticker-Specific Updates for Smart Investing
Insider Monkey
4 days ago
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3
Argus Research
5 days ago
CERT: Raising target price to $10.00
Thomson Reuters StreetEvents
10 days ago
Q3 2024 Certara Inc Earnings Call
GuruFocus.com
10 days ago
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Zacks
11 days ago
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
GlobeNewswire
11 days ago
Certara Reports Third Quarter 2024 Financial Results
Argus Research
12 days ago
CERT: What does Argus have to say about CERT?
GlobeNewswire
20 days ago
Certara to Participate in the Stephens Annual Investment Conference
Compare CERT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CERT Certara Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.